Psychological impact of the COVID-19 pandemic on patients with allergic diseases

González‐Díaz, Sandra Nora; Martin, Bryan; Villarreal-González, Rosalaura Virginia; Lira-Quezada, Cindy Elizabeth de; Macouzet-Sánchez, Carlos; Macías-Weinmann, Alejandra; Guzmán-Avilán, Rosa Ivett; García-Campa, Mariano; Noyola, Andrés; Garcia-Gonzalez, David Uriel

doi:10.1016/j.waojou.2021.100510

Cited by 22 publications

(25 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Social distancing during the COVID-19 lockdown, combined with increased fear of getting infected with SARS-CoV-2, could have a negative effect on anxiety and depression. 5 – 8 This is especially true for asthma patients, who are prone to anxiety and depression. 6 , 23 As asthma control and the asthma-related quality of life did not deteriorate between pre-COVID-19 and during the COVID-19 lockdown, we suggest that the increased HADS-Anxiety and HADS-Depression scores are related to the COVID-19 lockdown.…”

Section: Discussionmentioning

confidence: 99%

“…6 A deterioration of mental health in asthma patients and depression in allergic patients during the COVID-19 pandemic has recently been described. 7,8 It is not clear whether or not asthma is a risk factor for severe COVID-19. Several recent studies have not identified allergic asthma as a risk factor per se.…”

Section: Introductionmentioning

confidence: 99%

“… 6 A deterioration of mental health in asthma patients and depression in allergic patients during the COVID-19 pandemic has recently been described. 7 , 8 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic

et al. 2021

View full text Add to dashboard Cite

Population studies showed a decrease in psychological wellbeing during the COVID-19 pandemic. Asthma is associated with a negative effect on anxiety and depression, which might worsen during the COVID-19 lockdown. The aim of the study was to compare fear, anxiety and depression between asthma patients and patients wit hout asthma pre-COVID-19 and during COVID-19 pandemic. This study compares fear, anxiety and depression in asthma patients and controls between pre-COVID-19 and during COVID-19 lockdown with a cross-sectional online survey. Participants were invited to fill out several questionnaires pertaining to fear, anxiety, depression, asthma control and quality of life. Asthma patients (N = 37) displayed, during the course of the pandemic, a clinically relevant increase in anxiety (3.32 ± 2.95 vs. 6.68 ± 3.78; p < 0.001) and depression (1.30 ± 1.15 vs. 3.65 ± 3.31; p < 0.001), according to the hospital anxiety and depression levels (HADS) compared to pre-COVID-19 assessment. This was not seen in controls. Also, asthma patients displayed more anxiety about acquiring COVID-19 disease compared to controls ((5.11 ± 1.99 vs. 3.50 ± 2.79), p = 0.006). Patients with asthma experienced an increase in anxiety and depression levels and were more afraid of acquiring COVID-19 disease compared to controls. Also, patients with asthma were more likely to avoid healthcare facilities due to fear of acquiring COVID-19 disease compared to controls. Therefore, we advise health care workers to address these possible negative effects on mental health by phone or e-consults.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic

et al. 2021

View full text Add to dashboard Cite

show abstract

“…A cross-sectional study has shown that depression and reported post-traumatic stress disorder are present in individuals with allergic diseases during the COVID-19 pandemic. 78 However, a study from Wuhan, China, using a before-and-after COVID-19 infection approach has indicated that the psychological status of AR patients was not significantly influenced by the COVID-19 infection. 79 Efficient and safe COVID-19 vaccines are still under investigation.…”

Section: Re Al-world E Viden Ce-oriented G Uidelinementioning

confidence: 99%

Advances and highlights in allergic rhinitis

Zhang

Feng

Zhang

2021

Allergy

110

View full text Add to dashboard Cite

show abstract

“…Unfortunately, the authors didn't distinguish between patients with allergic asthma from patients with AR (18). Even if at the beginning of the COVID-19 pandemic asthma and allergy were considered as possible risk factors for COVID-19, subsequent statements from international societies and expert scientific bodies concluded that allergic respiratory diseases do not constitute risk factors for severe COVID-19 (10,14).…”

Section: F O R P U B L I C a T I O Nmentioning

confidence: 99%

Allergic rhinitis and COVID-19: friends or foes?

Gani¹,

Cottini²,

Landi

et al. 2022

Eur Ann Allergy Clin Immunol

View full text Add to dashboard Cite

Allergic rhinitis (AR) is a common disease affecting up to 40% of the general population worldwide.In the Coronavirus 2019 (COVID-19) pandemic era, many observational studies analysing the effect of asthma and chronic obstructive pulmonary disease on the risk of developing COVID-19 were conducted, while data on AR are limited.In this paper, we review the risk of developing SARS-Cov-2 infection carried by AR patients, the outcomes of those with COVID-19 disease, and the COVID-19 influence on the allergic and nasal symptoms and the psychological status of AR patients, in both adult and paediatric populations.AR patients seem to be protected from COVID 19 infection. Even if data about the influence of AR on the severity of COVID-19 disease are still not conclusive, it seems that being an AR patient does not increase the risk of poor COVID-19 prognoses. The clinical manifestation of AR can be distinguished by COVID-19 symptoms. Treating AR adequately is also strongly recommended, especially during pandemic.

show abstract

Psychological impact of the COVID-19 pandemic on patients with allergic diseases

Cited by 22 publications

References 33 publications

Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic

Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic

Advances and highlights in allergic rhinitis

Allergic rhinitis and COVID-19: friends or foes?

Contact Info

Product

Resources

About